The main active agent in green tea, EGCG, prevents the first step
in HIV infection and could one day be used as a new anti-HIV drug,
suggests a new study this week. Japanese researchers report that
the extract, already believed to...
Experts attending this week's meeting on cancer prevention heard a
number of studies to back green tea's powerful anti-cancer effects
in humans. The tea's active agent, Epigallocatecin-3-gallate, is
already thought...
The active ingredient in green tea, epigallocatechin-3-gallate
(EGCG), has been found to block the growth of bladder tumours in
rats, suggesting the chemical could be used to prevent bladder
cancer.
